Combinations of hepatitis C virus inhibitors
US8415374B2 · kind B2 · utility
11Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2010 |
| Grant date | Apr 9, 2013 |
| Priority date | — |
| Expiry date | Feb 10, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.